An in-depth guide from the team at Paradise Medical Center Primary Care in Miami, FL.
Call (305) 676-8217For decades, weight loss was framed as a willpower problem. Today we know it's a medical, biological, and hormonal condition — and we have treatments that actually work. Modern medical weight loss combines proven medications, structured behavioral coaching, and metabolic monitoring for results comparable to bariatric surgery.
Here are your evidence-based options.
Sustained weight loss through diet and exercise alone produces only 5–10% weight loss on average — and most patients regain it within 2–3 years due to powerful biological compensation (slowed metabolism, increased hunger hormones).
This isn't a personal failing. It's biology. Modern medications directly counteract these compensatory mechanisms.
GLP-1 receptor agonists are the most effective weight loss medications ever developed. They work by:
Reducing appetite and food cravings
Slowing gastric emptying (you feel full longer)
Improving insulin sensitivity
Reducing 'food noise' in the brain
Available medications:
Semaglutide (Wegovy): 15% average body weight loss over 68 weeks.
Tirzepatide (Zepbound): 20–22% average body weight loss — the most effective to date.
Liraglutide (Saxenda): Earlier-generation, daily injection.
These are FDA-approved specifically for weight management. The diabetes versions (Ozempic, Mounjaro) work the same way and are used for patients with type 2 diabetes.
FDA approval criteria for weight-management GLP-1s:
BMI 30+ (obesity), or
BMI 27+ with at least one weight-related condition (high blood pressure, type 2 diabetes, sleep apnea, high cholesterol)
We help with insurance prior authorization and discuss coverage options. See our obesity & metabolic syndrome guide.
Most common: nausea, mild fatigue, occasional diarrhea or constipation. These typically improve over the first weeks as dose is gradually increased.
Slow dose escalation, hydration, smaller meals, and dietary adjustments minimize side effects significantly. Most patients tolerate medication well long-term.
Phentermine: Older appetite suppressant; useful short-term for some patients.
Phentermine-topiramate (Qsymia): Combination producing 8–10% weight loss.
Naltrexone-bupropion (Contrave): Targets reward-related eating.
Orlistat: Blocks fat absorption (significant GI side effects).
Medications alone don't teach sustainable habits. We provide structured counseling on:
Mediterranean-style or low-carb eating patterns
Practical meal planning and grocery strategies
Resistance training (preserving lean mass during weight loss)
Sleep optimization (poor sleep substantially impairs weight loss)
Stress and emotional eating patterns
Bilingual coaching in English and Spanish.
Many weight-loss patients benefit from B12 injections to maintain energy during caloric reduction. B12 supports metabolism, mood, and stamina.
Obesity is a chronic disease — like hypertension or diabetes. Most patients require ongoing treatment to maintain weight loss. Stopping medication often results in regain over time.
We coordinate long-term care through our chronic care management program with monthly check-ins. The Obesity Medicine Association emphasizes that obesity treatment is lifelong, just like other chronic disease care.
Ready to learn more? Visit our dedicated service page or call (305) 676-8217 to schedule a consultation.
On Wegovy: ~15%. On Zepbound: 20–22%. Combined with structured lifestyle changes, results can exceed these averages.
Coverage varies. Diabetes-indicated GLP-1s (Ozempic, Mounjaro) are widely covered. Pure weight-loss versions (Wegovy, Zepbound) have variable coverage. We help navigate authorization.
Most patients regain weight without ongoing treatment. Long-term maintenance is part of the plan.
Yes — strong long-term safety data. Side effects are usually mild GI symptoms.
Yes — Wegovy and Zepbound are FDA-approved for weight management in patients without diabetes.
Speak with our medical team about a personalized plan.
Call (305) 676-8217